Future access to COVID vaccines could be restricted due to the FDA policy

The US Food & Drug Administration (FDA) has said it will require more data from further clinical trials before the approval of coronavirus vaccines for people not considered to be at heightened risk from severe sickness. It’s a departure from the one-size-fits-all approach that’s largely defined the vaccination policy until now. However, the government said that 100-200 million people will have annual access.